TrialDiabetes care2022

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.

Peter Rossing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.